Client: N.V. Nederlandsch Octrooibureau (Netherlands)
Patent Applicant: Aurigene Oncology Limited (India) — biopharmaceutical company focused on oncology innovation
Legal Support Area: PCT national phase entry in Ukraine
Project Summary
In April 2023, Polikarpov Law Firm filed a PCT national phase patent application in Ukraine on behalf of Aurigene Oncology Limited, coordinated by N.V. Nederlandsch Octrooibureau. The invention, titled “Heterocyclic compounds as CBP/EP300 bromodomain inhibitors,” relates to novel cancer treatment agents targeting specific epigenetic mechanisms.
We provided full support, including translation, editing, and filing of the application in compliance with Ukrainian legal standards.
Client’s Goals
- Enter the national phase of the PCT application in Ukraine on time
- Secure IP protection for a novel therapeutic invention
- Integrate Ukrainian protection into a global patent strategy
Project Complexity
- High technical complexity involving oncology and epigenetics
- Need for accurate and legally compliant scientific translation
- Adhering to national formalities for pharmaceutical patents
Polikarpov Law Firm’s Actions
- Reviewed and translated the international application
- Prepared and filed the Ukrainian national phase application in April 2023
- Maintained ongoing communication with UANIPIO regarding the examination
- Provided full procedural support and client updates
Lawyers
Anton Polikarpov — Managing Partner, coordinated with N.V. Nederlandsch Octrooibureau
Anastasiia Shevchuk — Senior Associate, handled documentation and communication with the Ukrainian IP Office
Result
The application titled “Heterocyclic compounds as CBP/EP300 bromodomain inhibitors” was successfully filed in Ukraine and is currently under examination. Polikarpov Law Firm continues to support the process through to final patent grant.
